HomeAN6 • FRA
add
AnaptysBio Inc
Previous close
€18.30
Day range
€18.10 - €18.90
Year range
€12.30 - €24.60
Market cap
514.89M USD
Avg Volume
4.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 9.00M | 32.27% |
Operating expense | 10.28M | 9.24% |
Net income | -42.21M | -59.81% |
Net profit margin | -468.75 | -20.82% |
Earnings per share | -1.59 | -70.97% |
EBITDA | -34.63M | -34.29% |
Effective tax rate | 0.01% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 390.90M | -11.41% |
Total assets | 452.39M | -25.88% |
Total liabilities | 364.29M | 4.60% |
Total equity | 88.10M | — |
Shares outstanding | 26.76M | — |
Price to book | 5.53 | — |
Return on assets | -18.51% | — |
Return on capital | -20.08% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -42.21M | -59.81% |
Cash from operations | -34.35M | -221.47% |
Cash from investing | 49.18M | 128.77% |
Cash from financing | -5.16M | -364.70% |
Net change in cash | 9.67M | -24.22% |
Free cash flow | -19.16M | -125.46% |
About
Founded
2005
Headquarters
Website
Employees
117